{
    "2018-05-18": [
        [
            {
                "time": "2018-05-18",
                "original_text": "[买入评级]中航沈飞(600760)公司信息点评：主机厂首个限制性股票激励计划出台 受益列装需求+“贴身经营”激励 看好公司未来进入成长高速期",
                "features": {
                    "keywords": [
                        "中航沈飞",
                        "限制性股票激励",
                        "列装需求",
                        "贴身经营",
                        "成长高速期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "航空制造"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-18",
                "original_text": "中航沈飞：核心机型高景气 业绩稳健增长",
                "features": {
                    "keywords": [
                        "中航沈飞",
                        "核心机型",
                        "高景气",
                        "业绩稳健增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "航空制造"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-18",
                "original_text": "30股获券商买入评级 瑞康医药目标涨幅达49.36%",
                "features": {
                    "keywords": [
                        "瑞康医药",
                        "买入评级",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-18",
                "original_text": "早安！方正最新观点20180518",
                "features": {
                    "keywords": [],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}